SCHEMBL1712693

SCHEMBL1712693

CNC1CCN(C=O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21069201 1.00
SCHEMBL24615140 1.00
SCHEMBL20281923 0.89 ADH1B (0.33)
SCHEMBL2389051 0.86 CTSL (0.33)
SCHEMBL13030251 0.81
SCHEMBL21936191 0.78
SCHEMBL31679143 0.78 CTSL (0.38)
SCHEMBL1306525 0.78 CTSL (0.38)
SCHEMBL24501917 0.78 CTSL (0.38)
SCHEMBL3953970 0.76 CA1 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250206730-A1 THIAZOLE DERIVATIVE COMPOUND AND USES THEREOF AUTOTELIC BIO INC. (KR) 2025-06-26 US claimed
EP-4501928-A1 THIAZOLE DERIVATIVE COMPOUND AND USES THEREOF Autotelic Bio Inc. (KR) 2025-02-05 EP claimed
CN-119255993-A Thiazole derivative compound and use thereof 奥托泰利克生物公司 2025-01-03 CN claimed
EP-2215085-B1 PYRIDINE AND PYRAZINE DERIVATIVES USEFUL IN THE TREATMENT OF CELL PROLIFERATIVE DISORDERS ASTRAZENECA AB (SE) 2011-09-07 EP claimed
EP-2215085-A2 PYRIDINE AND PYRAZINE DERIVATIVES USEFUL IN THE TREATMENT OF CELL PROLIFERATIVE DISORDERS AstraZeneca AB (SE) 2010-08-11 EP claimed
CN-101511840-A Phosphoinositide 3-kinase inhibitor compounds and methods of use thereof GENENTECH INC (US) 2009-08-19 CN claimed
US-20090118305-A1 PYRIDINE AND PYRAZINE DERIVATIVES - 083 ASTRAZENECA AB (SE) 2009-05-07 US claimed
WO-2009053737-A2 PYRIDINE AND PYRAZINE DERIVATIVES USEFUL IN THE TREATMENT OF CELL PROLIFERATIVE DISORDERS ASTRAZENECA AB (SE) 2009-04-30 WO claimed
US-12454534-B2 Pyrrolo[2,3-b]pyrazines as HPK1 inhibitor and the use thereof BEONE MEDICINES I GMBH (CH) 2025-10-28 US disclosed
US-20250206730-A1 THIAZOLE DERIVATIVE COMPOUND AND USES THEREOF AUTOTELIC BIO INC. (KR) 2025-06-26 US disclosed
US-20250043353-A1 BIOMARKERS OF RESPONSE TO SELECTIVE INHIBITORS OF AURORA A KINASE MILLENNIUM PHARM INC (US) 2025-02-06 US disclosed
EP-4501928-A1 THIAZOLE DERIVATIVE COMPOUND AND USES THEREOF Autotelic Bio Inc. (KR) 2025-02-05 EP disclosed
CN-119255993-A Thiazole derivative compound and use thereof 奥托泰利克生物公司 2025-01-03 CN disclosed
CN-115073474-B Pyrrolo [2,3-b ] pyrazines as HPK1 inhibitors and uses thereof 百济神州有限公司 2024-10-18 CN disclosed
EP-2345629-A1 FLUORENE COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES Japan Tobacco, Inc. (JP) 2011-07-20 EP disclosed
US-20100240634-A1 Fluorene Compound and Pharmaceutical Use Thereof JAPAN TOBACCO INC. (JP) 2010-09-23 US disclosed
EP-2215085-A2 PYRIDINE AND PYRAZINE DERIVATIVES USEFUL IN THE TREATMENT OF CELL PROLIFERATIVE DISORDERS AstraZeneca AB (SE) 2010-08-11 EP disclosed
CN-101511840-A Phosphoinositide 3-kinase inhibitor compounds and methods of use thereof GENENTECH INC (US) 2009-08-19 CN disclosed
US-20090118305-A1 PYRIDINE AND PYRAZINE DERIVATIVES - 083 ASTRAZENECA AB (SE) 2009-05-07 US disclosed
WO-2009053737-A2 PYRIDINE AND PYRAZINE DERIVATIVES USEFUL IN THE TREATMENT OF CELL PROLIFERATIVE DISORDERS ASTRAZENECA AB (SE) 2009-04-30 WO disclosed